Polymerizable compound having triple bond, liquid crystal composition and liquid crystal display device
US-2015376505-A1 · Dec 31, 2015 · US
US9518004B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9518004-B2 |
| Application number | US-201314649369-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 2, 2013 |
| Priority date | Dec 3, 2012 |
| Publication date | Dec 13, 2016 |
| Grant date | Dec 13, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A reduced coenzyme Q 10 derivative represented by formula (1), wherein R 1 and R 2 are each independently H or an alkoxycarbonyl group represented by formula (2), and at least one of them is an alkoxycarbonyl group represented by the formula (2); in the formula (2), R 3 is an optionally substituted linear, branched, or cyclic alkyl group having 1 to 20 carbon atoms, an optionally substituted aryl group having 6 to 20 carbon atoms, or an optionally substituted heteroaryl group having 4 to 20 carbon atoms, and when R 3 is a group substituted with polyethylene glycol, the molecular weight of the polyethylene glycol is not more than 300.
Opening claim text (preview).
The invention claimed is: 1. A reduced coenzyme Q 10 derivative represented by formula (1), wherein R 1 and R 2 are each independently H or an alkoxycarbonyl group represented by formula (2), and at least one of R 1 and R 2 is an alkoxycarhonyl group represented by formula (2), and R 3 is a linear, branched, or cyclic alkyl group having 1 to 6 carbon atoms, or an aryl group having 6 to 10 carbon atoms. 2. The reduced coenzyme Q 10 derivative according to claim 1 , wherein R 1 and R 2 are the same. 3. A crystal of a reduced coenzyme Q 10 derivative represented by formula (1), wherein R 1 and R 2 are each independently H or an alkoxycarbonyl group represented by formula (2), and at least one of R 1 and R 2 is an alkoxycarbonyl group represented by formula (2), and R 3 is a linear, branched, or cyclic alkyl group having 1 to 6 carbon atoms, or an aryl group having 6 to 10 carbon atoms. 4. The crystal of the reduced coenzyme Q 10 derivative according to claim 3 , wherein R 3 is an ethyl group, an isopropyl group, an isobutyl group, a cyclopentyl group, or a phenyl group. 5. The crystal of the reduced coenzyme Q 10 derivative according to claim 3 , wherein R 1 and R 2 are the same. 6. A method for producing the reduced coenzyme Q 10 derivative according to claim 1 , comprising: reacting reduced coenzyme Q 10 represented by formula (3): with an alkoxycarbonylation agent in the presence of a base. 7. The method according to claim 6 , further comprising: forming crystals in an organic solvent. 8. The method according to claim 7 , wherein the organic solvent comprises one or more organic solvents selected from the group consisting of a nitrile, an alcohol, an aliphatic hydrocarbon, an aromatic hydrocarbon, a halogenated hydrocarbon, an ether, and an ester. 9. The method according to claim 7 , wherein the organic solvent is at least one of a nitrile and an alcohol. 10. The method according to claim 8 , wherein the organic solvent is a nitrile. 11. The method according to claim 10 , wherein the nitrile is acetonitrile. 12. The method according to claim 8 , wherein the organic solvent is an alcohol. 13. The method according to claim 12 , wherein the alcohol is ethanol. 14. The reduced coenzyme Q 10 derivative according to claim 1 , wherein R 1 and R 2 are each represented by the formula (2). 15. The crystal of the reduced coenzyme Q 10 derivative according to claim 3 , wherein R 1 and R 2 are each represented by the formula (2). 16. The crystal of the reduced coenzyme Q 10 derivative according to claim 4 , wherein R 1 and R 2 are the same. 17. The reduced coenzyme Q 10 derivative according to claim 1 , wherein R 3 is an ethyl group, an isopropyl group, a n-butyl group, an isobutyl group, a tert-butyl group, a cyclopentyl group, or a phenyl group. 18. The reduced coenzyme Q 10 derivative according to claim 1 , wherein R 3 is an isopropyl group, a cyclopentyl group, or a phenyl group. 19. The reduced coenzyme Q 10 derivative according to claim 18 , wherein R 1 and R 2 are the same. 20. The crystal of the reduced coenzyme Q 10 derivative according to claim 3 , wherein R 3 is a linear, branched, or cyclic alkyl group having 2 to 6 carbon atoms.
Preparation of esters of carbonic or haloformic acids · CPC title
Esters of carbonic or haloformic acids · CPC title
the ring being saturated · CPC title
Purification; Separation; Stabilisation · CPC title
Chemistry & Metallurgy · mapped topic
Related publications grouped by family.
Answers are generated from the same data shown on this page.